Indian Tobacco Company Reports Strong Q2 2022 Performance

Aug.07.2022
Indian Tobacco Company Reports Strong Q2 2022 Performance
Indian Tobacco Company (ITC) reported strong Q2 performance with revenue and earnings growing 29% and 30.1% respectively.

According to a report from ITC (formerly known as the Indian Tobacco Company Limited, now the Indian Tobacco Company), their cigarette business achieved strong performance in the second quarter of 2022, with segment revenue and segment performance increasing by 29% and 30.1%, respectively, compared to the same period in the previous year.


Photo courtesy of Wirestock.


The Indian Tobacco Company released a statement declaring their commitment to combatting illegal trade. They plan to strengthen their market position through innovation, market segmentation, premiumization, improving product availability, and strict enforcement.


The Indian Tobacco Company has expressed encouragement towards the stable tobacco tax environment and enforcement actions taken by Indian authorities to eliminate illegal trade.


The Indian Tobacco Company stated in a press release that "as demonstrated in the past, stable cigarette taxes, supported by deterrent law enforcement actions, enable the legal cigarette industry to recover trade volumes from illegal trade, generating domestic demand for Indian tobacco, while also alleviating fiscal revenue losses.


The Indian Tobacco Company has stated that it continues to work with government agencies to develop a fair, non-discriminatory, practical, and evidence-based regulatory and taxation policy framework that balances economic benefits and tobacco control objectives. This takes into account India's unique patterns of tobacco consumption, with only a small portion of combustible tobacco production being used to manufacture cigarettes in Indian factories.


Statement:


This article is compiled from third-party information and is intended only for communication and learning within the industry.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truth or accuracy of the content. The translation of this article is only for industry communication and research purposes.


Due to limited translation abilities, the translated article may not fully reflect the original text. Please refer to the original version for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of compiled information belongs to the original media outlet and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Exhibition Insights | Beyond Devices: What RELX’s Multi-Format Display Suggests About Category Expansion
Exhibition Insights | Beyond Devices: What RELX’s Multi-Format Display Suggests About Category Expansion
RELX’s booth in Prague brought together vaping devices, RELX-branded e-liquids, oral nicotine products and a nasal product concept in one display. Rather than centering the booth on a single hardware line, the company presented multiple product paths side by side.
Apr.20 by 2FIRSTS.ai
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Calls Tobacco Industry “Criminal” After Court Undermines Supermarket Sales Ban
Belgian Health Minister Frank Vandenbroucke described the tobacco industry as a “criminal” sector with “no future” during an appearance on VRT’s current affairs program Ter Zake. His comments came after Belgium’s Constitutional Court ruled that a government ban on cigarette and vape sales in supermarkets was discriminatory because it allowed small shops to sell tobacco products while prohibiting larger retailers from doing so.
May.07 by 2FIRSTS.ai
Philippine Anti-Smoking Groups Urge DTI Action Over Alleged Vape Law Violations by ZYN and IQOS
Philippine Anti-Smoking Groups Urge DTI Action Over Alleged Vape Law Violations by ZYN and IQOS
Several anti-smoking and health advocacy groups in the Philippines urged the Department of Trade and Industry to take action against tobacco companies accused of violating the Vape Regulation Act of 2022. The groups said three consecutive complaints had been filed involving nicotine pouch brand ZYN and heated tobacco product company IQOS Philippines.
Apr.27 by 2FIRSTS.ai
UK Retailers Call on Government to Better Resource Trading Standards to Fight Illicit Tobacco and Vape Trade
UK Retailers Call on Government to Better Resource Trading Standards to Fight Illicit Tobacco and Vape Trade
Retailers in the UK have called on the government to provide greater resources to Trading Standards in response to the growing trade in illicit tobacco and vapes. Fed national vice-president Hemanshu Patel made the call during a panel discussion at the National Convenience Show in Birmingham on April 15.
Apr.21 by 2FIRSTS.ai
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1
Imperial Brands released a trading update on April 14, reiterating its FY26 guidance and saying its 2030 transformation has started positively. The company said it still expects low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% growth in Group adjusted operating profit, at least high-single-digit earnings per share growth, and at least GBP 2.2 billion in free cash flow for the full year.
Apr.14 by 2FIRSTS.ai